Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
Nature Microbiology|December 20, 2016
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.Gastroenterology|March 15, 2018
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in HepatocytesOliver Grünvogel, Ombretta Colasanti, Ji-Young Lee, et al.JHEP Reports : Innovation in Hepatology|April 26, 2026
Robust HLA-B-restricted CD8+ T cell responses in chronic HBV infectionJulia Lang-Meli, Anna-Lena Denecke, Johannes Ptok, et al.Hepatology (Baltimore, Md.)|December 25, 2009
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeChristoph Neumann-Haefelin, Jörg Timm, Julia Schmidt, et al.Journal of Hepatology|August 28, 2022
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJulia Dietz, Beat Müllhaupt, Peter Buggisch, et al.JHEP Reports : Innovation in Hepatology|July 24, 2026
Fate of hepatitis D virus-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta☆Valerie Oberhardt, Elisabetta Degasperi, Michelle Maas, et al.Nature Communications|August 8, 2022
COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivationMatthias Reinscheid, Hendrik Luxenburger, Vivien Karl, et al.Hepatology (Baltimore, Md.)|October 19, 2011
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutationsChristoph Neumann-Haefelin, Cesar Oniangue-Ndza, Thomas Kuntzen, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 10, 2019
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 InfectionsJulia Dietz, Ulrich Spengler, Beat Müllhaupt, et al.Frontiers in Immunology|November 28, 2022
Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I allelesAndreas Walker, Tatjana Schwarz, Janine Brinkmann-Paulukat, et al.Pageof 15